NCT02692287

Brief Summary

The Postpartum Haemorrhage (PPH) Butterfly is a simple, low-cost device which has been developed as a treatment method for PPH. It will be used to stop the bleeding through compression of the uterus of women having a PPH. It will be markedly easier to undertake than traditional bimanual compression, whilst also being significantly more acceptable to women themselves. Use of the PPH Butterfly will provide an alternative management option for PPH and in some cases should avoid the need for women to have to go to theatre for treatment. This research will allow the investigators to determine if they have the optimum size and shape of the device, that it will operate as intended when compressing the uterus, and to gauge its acceptability to participants and users. In phase I the investigators will recruit "healthy volunteers" i.e. women who have delivered their baby vaginally following Induction of labour (IOL) however these women will not be experiencing a PPH. The device is to be assessed purely on size, usability and acceptability not for diagnosis or as a treatment method. Following the delivery participants will be invited to have the PPH Butterfly inserted vaginally for an average of 2 minutes. It is through this that the investigators will assess the suitability of the device in its current design, when it is in practice. The clinician who operates the device will complete a Likert scale questionnaire along with some open questions following each administration. Participants will also answer a short questionnaire. .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2016

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 26, 2016

Completed
4 days until next milestone

Study Start

First participant enrolled

March 1, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

March 6, 2018

Status Verified

March 1, 2018

Enrollment Period

1 year

First QC Date

February 12, 2016

Last Update Submit

March 3, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of participants for whom the PPH Butterfly is the correct size

    This outcome measure will be assessed through the use of a Likert scale questionnaire

    Up to 8 weeks

Study Arms (1)

Use of the PPH Butterfly

OTHER

The PPH Butterfly will be inserted into the vagina of a healthy postnatal woman

Device: The PPH Butterfly

Interventions

The PPH Butterfly is a simple, low cost device that has been developed to facilitate less invasive compression of the uterus in a PPH

Use of the PPH Butterfly

Eligibility Criteria

Age16 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Women who have a vaginal delivery following induction of labour and who are within 72 hours of delivery.

You may not qualify if:

  • Women assessed antenatally to have learning difficulties that may have the potential to impair their decision making
  • Women aged \< 16 years of age
  • Women who cannot read or understand the level of English used in the study documentation
  • Women who've had a stillbirth (in this pregnancy)
  • Women who have undergone Female Genital Mutilation/vaginal surgery which is unreversed (assessed antenatally)
  • Women with clotting disorders; either longstanding or following intrapartum events
  • Women who have just had, or are having an ongoing PPH
  • Women in whom the third stage of labour is not complete (placenta remains in situ).
  • Women who have had a caesarean section

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Liverpool Womens Hospital

Liverpool, Merseyside, L8 7SS, United Kingdom

Location

MeSH Terms

Conditions

Postpartum Hemorrhage

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPuerperal DisordersUterine HemorrhageHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Andrew Weeks

    University of Liverpool

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Model Details: If the device is not of the correct size, then the device is changed and the recruitment process is repeated until the correct size is obtained.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor of International Maternal Health

Study Record Dates

First Submitted

February 12, 2016

First Posted

February 26, 2016

Study Start

March 1, 2016

Primary Completion

March 1, 2017

Study Completion

April 1, 2017

Last Updated

March 6, 2018

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share

Locations